Project Grant HT94252510453
Award Date
6/15/25
Completion Date
6/14/28
Dollars Obligated
$785K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92697, USA
Similar Awards
The Defense Health Agency awarded a $553,725 Project Grant to the University of California, Berkeley under the Military Medical Research and Development program (CFDA 12.420) to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The grant, which runs from August 1, 2024 to July 31, 2028, will enable UC Berkeley to conduct research to determine whether acupuncture provides a viable treatment option for the medical issues affecting veterans of the Gulf War. As a...
This federal Project Grant award of $1,539,865.00, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), is supporting research at the University of Utah to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The project, set to run from August 1, 2024 to July 31, 2028, will leverage the university's expertise in biomedical research and healthcare services to advance knowledge in this critical area. The...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $523,266 project grant to the University of California Irvine. The 3-year grant, awarded on Sep 15, 2023, will support intravital imaging research on melanoma tumors to improve understanding of the mechanisms of action and patient surveillance for checkpoint blockade immunotherapy. The project aims to leverage UC Irvine's research capabilities and specialized facilities in biomedical...
The U.S. Department of Defense (DoD) awarded a $784,963 Project Grant to the University of California, Irvine (UC Irvine) under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, which began on September 15, 2023, funds research focused on "Interactions of Fine Particulate Matter Exposure and Gonadal Toxicity on Alzheimer's Disease Progression." UC Irvine, as a leading public research university with expertise across biomedical disciplines, will...
The Department of the Army Medical Command awarded a $1.85 million Project Grant to Texas A&M University System Health Science Center to support research probing neuroinflammation in Gulf War illness via studies on Gulf War veteran-derived microglia. The grant was awarded on September 30, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will run through September 29, 2025. As part of the award, $150,000 in sub-award funding was provided to Drexel...
The University of California Irvine was awarded a $1,413,000 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on an epigenetic approach for alleviating enzalutamide resistance in prostate cancer. This 3-year research project, with a start date of June 1, 2024 and an expected completion date of May 31, 2027, aims to develop innovative treatments for prostate cancer patients who have become resistant to the...
This federal Project Grant award, valued at $2,520,000.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The primary awardee, the University of California, Los Angeles (UCLA), will leverage its extensive facilities, diverse faculty expertise, and robust administrative capabilities...
This $1,557,266 federal Project Grant was awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) grant program. The grant supports a 4-year research project led by the University of California, Los Angeles (UCLA) to elucidate the molecular pathways by which pro-inflammatory microbes induce the development of interstitial cystitis. The research aims to transform healthcare for military service members and the general public through...
The federal Project Grant award of $860,998.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award will fund advanced biomedical research focused on the "Neurophysiology of Post-Traumatic Epilepsy: Unraveling Epileptogenesis Signals Biomarkers" at the University of California, San Francisco (UCSF) from April 1, 2025 to March 31, 2028. UCSF, a prominent academic medical center and research...
This $1,994,937 federal Project Grant award, funded by the U.S. Department of Defense through the Military Medical Research and Development program (CFDA 12.420), is supporting research to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The grant recipient, Beth Israel Deaconess Medical Center, Inc. (Bidmc), a prominent academic medical center in Boston, will conduct this research project over a 4-year period from August 2024 to July 2028. Bidmc has...